A clinical trial on vitiligo

Comparative study on clinical evaluation of Mayiliragaadhi chooranam (internal ) and Kandangkathiri ennai (external)versus kandangkathiri Ennai (external)only-a siddha drug for Venpadai(vitiligo)- as Pilot study. - vitiligo

Status

Recruiting

Phases

Phase 2

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2018/02/012071

Enrollment

Registered

2018-02-22

Start date

Unknown

Completion date

Unknown

Last updated

2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: null- hypopigmented patches on the body

Interventions

Intervention1: mayiliragadhi chooranam (internal medicine) kandangathiri ennai (external medicine): oral administration 1gm b.i.d for 48 days Control Intervention1: nil: nil

Eligibility

Inclusion criteria

Inclusion criteria: Age: Between 5 to 12 years Sex: Both male and female children Hypo pigmented patches with hyper pigmented border without any structural changes in any part of the body Willing to co operate for taking photographs whenever required with hisher consent

Exclusion criteria

Exclusion criteria: 1.Albinism 2.Thyroid disorder 3.Leprosy 4.HIV 5.Fungal infestation 6.Burns Patient with lesion in the lips ,sole , palm and genitalia

Design outcomes

Primary

Measure	Time frame
Reduction of the hypopigmented lesions in the affected areaTimepoint: 45 days after medications	—

Secondary

Measure	Time frame
Reduction in the recurrence rate of the lesions.Timepoint: after 48 days	—

Countries

India

Contacts

Public ContactMMeenakshi sundaram

National Institute of Siddha

mmssiddha@rediffmail.com9444214582

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026